Purpose:

In this webinar we explore the current Generative AI state-of-play from the perspective of clients working in market research, data, and insights roles within pharma and life science. In the first half of the webinar, we will share findings from a series of stakeholder interviews Day One conducted with clients to explore where they are on their journeys and where they plan to go next. The second half of the session will be in the form of a virtual round table discussion with clients to bring to life the findings and debate the impact that Generative AI will have on our industry.

Webinar recording now available

Full BHBIA members only - you will need to log in to access it - once logged in, the link and password will appear on the page below this text.

What you can expect:

• Hear insights from clients regarding their experiences with adopting generative AI for market research and insights and assess the varying stages of adoption among different companies.
• Understand the perceived value of generative AI from the clients' perspective, including the pain points and opportunities they aim to address, as well as specific use cases.
• Share clients' predictions on how generative AI will reshape the industry, explore the evolving roles of technology and human expertise, and discuss what research agencies and fieldwork companies need to do to prepare for the future.

Who is the course/session aimed at:

This event is aimed at anyone working in market research, analytics and competitor intelligence, on either agency or industry side. It is suited to anyone who is responsible for developing, implementing or delivering new innovations and capabilities within their organisation or anyone who is interested in keeping up to date with where the industry is headed regarding the adoption of new technology. 

Speakers

Lawrence Hill – Consultant | Day One Strategy

LinkedIn: https://www.linkedin.com/in/lawrenceahill/

Lawrence specialises in digital healthcare and strategy. His experience spans competitive analysis, digital transformation, and innovation. With a robust background in innovation, consumer, and brand strategy, Lawrence has a proven track record of driving digital transformation initiatives within the healthcare sector and providing actionable insights to his clients. 

His expertise encompasses the application of Generative AI (GenAI) in healthcare, as well as the use of extended reality technologies, including augmented reality (AR) and virtual reality (VR), and digital therapeutics (Dtx) solutions.  

Notably, he played a key role in the creation, launch, and success of Day One Strategy’s AI Navigator, a community designed to guide healthcare organisations in adopting AI technologies effectively. More about this innovative tool can be found here https://www.ai-navigator.dayonestrategy.com/home 

As a consultant in Day One’s Digital Strategy team Lawrence is currently advising pharma companies on their generative AI strategy for market research and insights.

Dan Gallagher– Research Director | Day One Strategy

LinkedIn: https://www.linkedin.com/in/daniel-gallagher

Bio:

Dan has over eight years of experience in healthcare insights, specialising in qualitative, quantitative, and mixed methods research across various therapy areas. As one of the first employees at Day One Strategy, he has been instrumental in developing and implementing innovative methodologies that integrate technology with human insights.

Dan is a regularly speaks at industry events and facilitates training courses, including those organised by the BHBIA and EphMRA. Recent contributions include:

·      BHBIA Annual Conference 2024: "Human against Machine: A Critical Assessment of the Value of Synthetic Data

·      EphMRA Local Chapter Meeting London 2024: "Working in hAIrmony: Unleashing the Power of Practical Intelligence"

·      EphMRA Local Chapter Meeting London 2023: "Injecting Some Va Va Voom into Virtual Qual"

His passion for research was cultivated through both academic and commercial health research. Dan has expertise in project management, research design, new business development, and client management. His MSc dissertation, which explored the psychological effects of different exercise environments, led to a co-authored research paper published in the International Journal of Environmental Research and Public Health (IJERPH).

Dan has a broad expertise across numerous therapy areas, with a particular interest in novel therapies such as CAR T-Cell and other immunotherapies.

Notes: we will partner with a client (TBC) to lead this webinar